The efficiency of protein separation by ion-exchange chromatography could be increased by up to a factor of 5 according to a new study, potentially speeding up biopharmaceutical production.1 Christy Landes of Rice University in Texas (USA) and her team performed the first molecular-scale investigation into protein ion-exchange chromatography by using direct super-resolution techniques and the stochastic theory.
The efficiency of protein separation by ion-exchange chromatography could be increased by up to a factor of 5 according to a new study, potentially speeding up biopharmaceutical production.1 Christy Landes of Rice University in Texas (USA) and her team performed the first molecular-scale investigation into protein ion-exchange chromatography by using direct super-resolution techniques and the stochastic theory.
Ion-exchange chromatography is the primary technique used to separate proteins of interest from extracts during the manufacture of biopharmaceuticals, but it represents a “bottleneck” within the production process. Understanding the interactions between the mobile and stationary phases and using the stochastic theory of chromatography could enable tailoring of the stationary phase and therefore improve efficiency.
The project began with a hypothesis generated with collaborators in the Wilson group at the University of Houston. Landes told LCGC that the team believed that there was more to ion-exchange chromatographic separations than just electrostatic interactions; rather, that it depended on the specific clustering of adsorbents in a column. Landes said: “As usually happens with a great project, our need drove us to innovate. The goal to understand single protein adsorption at a realistic separations support caused us to look to the recent field of super-resolution imaging, but to expand that to measure the dynamics of proteins interacting with ligands.”
The team had already developed a super-resolution technique called mbPAINT (“motion blur” point accumulation for imaging in nanoscale topography) for mapping the capture and release of single DNA strands.3 DNA probes labeled with fluorescent tags were passed over immobilized single stranded DNA. On binding, even if just for a short time, a bright blur would be captured. Careful analysis of the images allowed the visualization of molecules smaller than the natural diffraction limits of light-based imaging.
Instead of using single stranded DNA, ligands were constructed on an agarose support matrix film. Peptides labeled with a fluorescent probe were passed over the ligands, and, on the formation of an interaction, released a signal that was captured by a camera. No more than a blur, multiple images were processed against the background distortion allowing the pinpoint of the location of the interaction. The interactions between single proteins and individual charged ligands were then quantified.
The paper demonstrated that clusters of charges are required to create adsorption sites and that even homogenously charged ligands can create alternate kinetics if the availability of the ligand is altered. Furthermore, the data was related to the stochastic model to suggest that clustering could be optimized by purposefully engineering ligand positions that currently exist accidentally.
When asked about the long-term importance of the results, Landes told LCGC: “Given the highly empirical methods currently used in the separations industry, and given the incredibly high and always rising cost of separations, we believe that molecular-scale insight such as provided in our paper could have a very high impact.” She added: “Any time a process occurs on a hundred billion dollar scale, as does the global pharmaceutical market, even small improvements can lead to serious savings. And that was one reason we included simulated separation curves in our work: They suggest that a 500% improvement could be made just by optimizing the clustering that currently occurs only by accident.”
References
1. L. Kisley, J. Chen, A.P. Mansur, B. Shuang, K. Kourentzi, M-V Poongavanam, W.H. Chen, S. Dhamane, R.C. Wilson, and C.F. Landes, PNAS 2014; published ahead of print January 23, 2014, DOI: 10.1073/pnas.1318405111
2. J. Chen, A. Bremauntz, L. Kisley, B. Shuang, and C.F. Landes, ACS Appl. Mater. Interfaces5(19), pp 9338–9343 (2013).
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.